Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1544 results
A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Charity News
  • Health & Medicine
  • Science & Technology

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

by Sadaf Shafaghmotlagh, Tim Gunn | In depth | 17 December 2024

17 December 2024

A cancer cell dividing.

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

by Tim Gunn | News | 6 December 2024

6 December 2024

Grapes

Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer. Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer.

by Sophie Wedekind | News | 11 November 2024

11 November 2024

A graphic showing analysis from a genomic test.
  • Science & Technology
  • Health & Medicine
  • Policy & Insight

The story of genomics - and our plan for its next chapter

Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK. Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK.

by Emily Eagles, Tim Gunn | In depth | 7 November 2024

7 November 2024

purple stained multiple myeloma cells

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

by Sophie Wedekind | News | 1 November 2024

1 November 2024

Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Science & Technology
  • Health & Medicine

12 ways we’ve influenced progress in lung cancer 

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer.

by Amy Warnock | 31 October 2024

31 October 2024

An illustration of a T cell

With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals. With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals.

by Jacob Smith | Analysis | 31 October 2024

31 October 2024

That Cancer Conversation in a white speech bubble with a dark blue background
  • Science & Technology
  • Health & Medicine

That Cancer Conversation podcast - Can I inherit cancer?

Welcome to another episode of Cancer Research UK's podcast, That Cancer Conversation. It's been 30 years since the discovery of BRCA genes, and to celebrate Sophie speaks to Professor Mike Stratton, who led the discovery of BRCA2, and a family who has the BRCA2 mutation. Welcome to another episode of Cancer Research UK's podcast, That Cancer Conversation. It's been 30 years since the discovery of BRCA genes, and to celebrate Sophie speaks to Professor Mike Stratton, who led the discovery of BRCA2, and a family who has the BRCA2 mutation.

by Cancer Research UK | Podcast | 30 October 2024

30 October 2024

This entry is part 22 of 30 in the series That Cancer Conversation
Colourful lollipops on a pink background.

Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably. Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably.

by Yvonne Ijeh, Tim Gunn | Analysis | 25 October 2024

25 October 2024

This entry is part 2 of 5 in the series Stand Up To Cancer
Yinka and Kola Bokinni holding Stand Up To Cancer donation jars

Every two years we fund exciting new projects through the Stand Up To Cancer (SU2C) campaign. Learn more about SU2C and some of our previous research projects in this new SU2C series. Every two years we fund exciting new projects through the Stand Up To Cancer (SU2C) campaign. Learn more about SU2C and some of our previous research projects in this new SU2C series.

by Nisharnthi Duggan | Analysis | 24 October 2024

24 October 2024

This entry is part 1 of 5 in the series Stand Up To Cancer
Brain scans

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

by Sophie Wedekind | News | 23 October 2024

23 October 2024